Phase III study of maribavir to treat transplant recipients for CMV infection meets primary endpoint Dec. 7, 2020
MTX-COVAB shows potent therapeutic and prophylactic activity in mode of advanced COVID-19 Dec. 7, 2020
Deglycosylated receptor-binding domain recombinant proteins as scalable SARS-CoV candidates Dec. 4, 2020